Mad in America January 1, 2024
Les Ruthven

Editor’s Note: Over the next several months, Mad in America is publishing a serialized version of Les Ruthven’s book, Much of U.S. Healthcare is Broken: How to Fix It. In this blog, he addresses the scientific literature on antidepressant efficacy and FDA approval. Each Monday, a new section of the book is published, and all chapters are archived here.

A brief review of the scientific literature on depression drug treatment outcome studies.

Some of the following studies appeared in my book Antidepressants: Science, Magic or Marketing,1 and in the next section, I will report on some of the more recent depression treatment outcome studies.

In some published FDA antidepressant placebo-controlled clinical trials, the response rate in terms of symptom reduction...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: FDA, Govt Agencies, Healthcare System
WellSpan Health's long-term population health strategy
FDA issues flu vaccine recommendations: 5 respiratory updates
Prioritizing Patient Safety and Quality Care Every Day for Everyone
Trump just withdrew his CDC director nomination. Here's why.
‘It’s Not About Beauty, It’s About Privacy’: How One Cancer Survivor Is Changing Chemo Care

Share This Article